Home > Healthcare > Medical Devices > Medical Supplies > Photoplethysmography (PPG) Biosensors Market

Photoplethysmography (PPG) Biosensors Market Size

  • Report ID: GMI6090
  • Published Date: Jun 2023
  • Report Format: PDF

Photoplethysmography Biosensors Market Size

Photoplethysmography Biosensors Market size was valued at USD 423.1 million in 2022 and is projected to reach at USD 1.2 billion by 2032. Photoplethysmography (PPG) biosensors are devices that utilize the technique of photoplethysmography to measure changes in blood volume in peripheral blood vessels.

 

PPG is a non-invasive optical method that provides information about the pulsatile component of blood flow. It involves illuminating the skin with a light source, usually a light-emitting diode (LED), and detecting the reflected or transmitted light using a photodetector. Moreover, advancements in sensor technology, miniaturization and low-power electronics have contributed to the development of PPG biosensors. These advancements have led to the integration of PPG sensors into smaller, wearable medical devices that offer improved accuracy, reliability, and battery life.

 

Furthermore, the market is primarily anticipated to increase due to the rising prevalence of cardiovascular diseases (CVD). For instance, in 2022, according to the Centers for Disease Control and Prevention (CDC), approximately 699,659 deaths occurred due to CVD in the U.S. Thus, the combination of this technique with technological advancements appears to proportionately increase the speed of cardiopathies' detection, improve medical care through remote patient monitoring and control and thereby reducing the number of CVD-related deaths. In addition, compared to electrocardiogram (ECG) sensors, PPG is a non-invasive, affordable method that can measure the signal at a variety of locations, including the fingers, toes, ears, wrists, chest, and heads.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Photoplethysmography (PPG) biosensors industry size was worth USD 423.1 million in 2022 and is estimated to reach USD 1.2 billion by 2032 owing to higher integration into smaller, wearable medical devices to offer improved accuracy, reliability, and battery life.

The smart watches product segment recorded USD 170.3 million in 2022 and is poised to gain significant prominence due to the continuous introduction of new innovative smartwatches.

U.S. market generated USD 143.9 million in 2022 and is projected to grow at a notable pace through 2032 driven by the increasing adoption of wearable health monitoring devices across the nation.

Some of the key market players include Apple Inc, Fitbit Inc, Samsung Electronics Co., Ltd., Garmin Ltd, Xiaomi Corporation, Omron Healthcare, Inc., Valencell. Inc, Mediatek, Masimo Corporation, Empatica Inc, among others.

Photoplethysmography (PPG) Biosensors Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 204
  • Countries covered: 30
  • Pages: 175
 Download Free Sample